Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Valneva Se (VLA.FP)

Valneva Se (VLA.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Valneva Se 6 Rue Alain Bombard Saint-Herblain 44800 FRA

P: +33 228073710

Description:

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.

Key Statistics

Overview:

Market Capitalization, $K 558,002
Shares Outstanding, K 139,153
Annual Sales, $ 153,712 K
Annual Net Income, $ -101,429 K
Last Quarter Sales, $ 32,753 K
Last Quarter Net Income, $ 58,909 K
% of Institutional Shareholders 10.53%

Growth:

1-Year Return -32.43%
3-Year Return -62.57%
5-Year Return 16.36%
5-Year Revenue Growth 6.34%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -0.73
EPS Growth vs. Prev Year -41.13%
Dividend Payout Ratio 0.00%

VLA.FP Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -12.38%
Return-on-Assets % -4.46%
Profit Margin % -65.99%
Debt/Equity 1.26
Price/Sales 3.62
Price/Cash Flow N/A
Price/Book 2.95
Book Value/Share 1.36
Interest Coverage -3.23
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar